Advisory Services Network’s Acadia Pharmaceuticals ACAD Stock Holding History

Advisory Services Network’s Portfolio ACAD Stock Details ACAD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,056	Closed	-$23.5K	–	2177
2026 Q1	$23.5K	Buy	+1,056	New	+$25.2K	﹤0.01%	3104
2024 Q1	–	Sell	-6	Closed	-$188	–	1461
2023 Q4	$188	Buy	+6	New	+$143	﹤0.01%	3738
2021 Q1	–	Sell	-25	Closed	-$1K	–	1286
2020 Q4	$1K	Buy	+25	New	+$1.24K	﹤0.01%	3099
2020 Q1	–	Sell	-1,648	Closed	-$71K	–	2994
2019 Q4	$71K	Buy	+1,648	New	+$71.7K	﹤0.01%	1323
2014 Q2	–	Sell	-10,715	Closed	-$261K	–	246
2014 Q1	$261K	Sell	10,715 -639	-6%	-$16.2K	0.13%	167
2013 Q4	$284K	Buy	+11,354	New	+$268K	0.14%	141

Other funds holding ACAD

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Advisory Services Network's ACAD Position: Q2 2026 in Review

Advisory Services Network sold out of Acadia Pharmaceuticals (ACAD) in Q2 2026, closing a stake of 1,056 shares — an estimated $23.5K sold.

Advisory Services Network first reported a position in ACAD in Q4 2013 and held it in 6 quarters. The position peaked at $284K in Q4 2013. 354 funds tracked by Wall St. Rank hold ACAD as of Q2 2026.

Advisory Services Network reported no remaining Acadia Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Advisory Services Network sold 1,056 Acadia Pharmaceuticals shares in Q2 2026, an estimated $23.5K.
Advisory Services Network first reported a position in Acadia Pharmaceuticals in Q4 2013 and held it in 6 quarters.
Advisory Services Network's Acadia Pharmaceuticals position peaked at $284K in Q4 2013.
354 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q2 2026.

Based on Advisory Services Network's 13F filing for Q2 2026, filed 12 Aug 2026.